Sign inJoin waitlistJoin the waitlist

WO

William K. Oh

Director, Precision Medicine · Yale Cancer Center and Smilow Cancer Hospital

Credentials: · · · · ·

History

Yale School of Medicine
Present

Research

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large,…
Journal of Clinical Oncology · 2009 · 1,772 citations
Treatment of muscle-invasive and advanced bladder cancer in 2020
Review · Current Anthropology · 2020 · 852 citations
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group
Journal of Clinical Oncology · 1999 · 847 citations

Matthew Galsky
94 papers
PK
Philip Kantoff
82 papers
CT
Che-Kai Tsao
48 papers · 2 as a fellow
MS
Matthew Smith
31 papers
Daniel George
26 papers
GS
Guru Sonpavde
22 papers
Vaibhav Patel
22 papers · 17 as a resident
Eric Small
20 papers
Bobby Liaw
18 papers
DK
Donald Kaufman
18 papers
Oliver Sartor
17 papers · 3 as a fellow
John Sfakianos
16 papers

Grants

DF/HCC SPORE in Prostate Cancer
National Cancer Institute · P50
Project lead · $1.4M · Dana-Farber Cancer Inst
2002–2013
A Phase II Study of IPI-504 in Metastatic Hormone Refractory Prostate Cancer
National Cancer Institute · R21
Contact PI · $532.4K · Dana-Farber Cancer Inst
2008–2010
NICHD Cooperative Multicenter Neonatal Research Network
National Institute of Child Health and Human Development · U10
Contact PI · $12.7M · Women and Infants Hospital-Rhode Island
1991–2006
Diabetes During Pregnancy: Effects on the Offspring
National Institute of Child Health and Human Development · P50
Contact PI · $4.7M · Women and Infants Hospital-Rhode Island
1977–1996

Clinical trials

Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Principal investigator · Completed · Phase 2
William K. Oh
2010–2013
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
Principal investigator · Completed · Phase 2
Infinity Pharmaceuticals, Inc.
2007–2010
Observational Study of Surgical Treatment of Necrotizing Enterocolotis
Principal investigator · Completed
NICHD Neonatal Research Network
2001–2004
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
Principal investigator · Completed
NICHD Neonatal Research Network
2001–2004